| Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories R De Jongh, I Bolt, M Schermer, B Olivier Neuroscience & Biobehavioral Reviews 32 (4), 760-776, 2008 | 285 | 2008 |
| Ethics in technological culture: a programmatic proposal for a pragmatist approach J Keulartz, M Schermer, M Korthals, T Swierstra Science, Technology, & Human Values 29 (1), 3-29, 2004 | 267 | 2004 |
| Ethical issues in deep brain stimulation M Schermer Frontiers in integrative neuroscience 5, 17, 2011 | 187 | 2011 |
| On the argument that enhancement is “cheating” M Schermer Journal of medical ethics 34 (2), 85-88, 2008 | 167 | 2008 |
| Ethical issues of digital twins for personalized health care service: preliminary mapping study P Huang, K Kim, M Schermer Journal of Medical Internet Research 24 (1), e33081, 2022 | 157 | 2022 |
| Opinions of health care professionals and the public after eight years of euthanasia legislation in the Netherlands: a mixed methods approach PSC Kouwenhoven, NJH Raijmakers, JJ Van Delden, JAC Rietjens, ... Palliative medicine 27 (3), 273-280, 2013 | 152 | 2013 |
| A tiered-layered-staged model for informed consent in personal genome testing EM Bunnik, ACJW Janssens, MHN Schermer European Journal of Human Genetics 21 (6), 596-601, 2013 | 144 | 2013 |
| The future of psychopharmacological enhancements: expectations and policies M Schermer, I Bolt, R De Jongh, B Olivier Neuroethics 2 (2), 75-87, 2009 | 142 | 2009 |
| Personal utility in genomic testing: is there such a thing? EM Bunnik, ACJW Janssens, MHN Schermer Journal of medical ethics 41 (4), 322-326, 2015 | 133 | 2015 |
| Moral enhancement: Do means matter morally? F Focquaert, M Schermer Neuroethics 8 (2), 139-151, 2015 | 123 | 2015 |
| The mind and the machine. On the conceptual and moral implications of brain-machine interaction M Schermer Nanoethics 3 (3), 217-230, 2009 | 118 | 2009 |
| The different faces of autonomy: patient autonomy in ethical theory and hospital practice M Schermer Springer, 2002 | 117* | 2002 |
| Pragmatist ethics for a technological culture FWJ Keulartz, M Korthals, M Schermer, TE Swierstra Springer Science & Business Media, 2002 | 116 | 2002 |
| Telecare and self-management: opportunity to change the paradigm? M Schermer Journal of medical ethics 35 (11), 688-691, 2009 | 111 | 2009 |
| Nothing but the truth? On truth and deception in dementia care M Schermer Bioethics 21 (1), 13-22, 2007 | 107 | 2007 |
| Psychological, behavioral and social effects of disclosing Alzheimer’s disease biomarkers to research participants: a systematic review S Bemelmans, K Tromp, EM Bunnik, RJ Milne, S Badger, C Brayne, ... Alzheimer's research & therapy 8 (1), 46, 2016 | 95 | 2016 |
| Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues EM Bunnik, MHN Schermer, ACJW Janssens BMC medical ethics 12 (1), 11, 2011 | 89 | 2011 |
| On the reconceptualization of Alzheimer’s disease MHN Schermer, E Richard Bioethics 33 (1), 138-145, 2019 | 88 | 2019 |
| The ethical desirability of moral bioenhancement: a review of reasons J Specker, F Focquaert, K Raus, S Sterckx, M Schermer BMC Medical Ethics 15 (1), 67, 2014 | 88 | 2014 |
| Enhancements, easy shortcuts, and the richness of human activities M Schermer Bioethics 22 (7), 355-363, 2008 | 88 | 2008 |
A. Cecile J.W. JanssensEmory University Rollins School of Public HealthVerified email at emory.edu
